{"mainPropery":{"diseaseId":2790,"diseaseName":"Glucocorticoid-remediable aldosteronism","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2790/glucocorticoid-remediable-aldosteronism","synonyms":["Familial hyperaldosteronism type 1","Hyperaldosteronism, familial  type 1","Dexamethasone sensitive hypertension","Glucocorticoid sensitive hypertension"],"synonyms-with-source":[{"name":"Familial hyperaldosteronism type 1"},{"name":"Hyperaldosteronism, familial  type 1"},{"name":"Dexamethasone sensitive hypertension"},{"name":"Glucocorticoid sensitive hypertension"}],"identifiers":[{"identifierType":"OMIM","identifierId":"103900"},{"identifierType":"ORPHANET","identifierId":"403"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/103900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='https://www.ncbi.nlm.nih.gov/gtr/conditions/C1260386/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=403' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=913&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:103900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Glucocorticoid-remediable aldosteronism. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Glucocorticoid-remediable aldosteronism:<br />\r\n<a href='http://www.brighamandwomens.org/Departments_and_Services/medicine/services/endocrine/Services/gra/default.aspx' target='_blank'>International Registry for Glucocorticoid-Remediable Aldosteronism</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":8940,"questionText":"What is&nbsp;Glucocorticoid-remediable aldosteronism?","answerText":"<strong>Glucocorticoid-remediable aldosteronism</strong> is one of three types of familial hyperaldosteronism. Aldosterone is a hormone manufactured by the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002219.htm\" target=\"_blank\">adrenal glands </a>which helps the body retain water and sodium and excrete potassium. It is caused by a fusion of the <em><a href=\"http://ghr.nlm.nih.gov/gene/CYP11B1\" target=\"_blank\">CYP11B1</a>&nbsp;and <a href=\"http://ghr.nlm.nih.gov/gene/CYP11B2\" target=\"_blank\">CYP11B2</a>&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a> </em> and is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>  manner. Individuals with this condition usually have hypertension (high blood pressure) before age 21. These individuals are also at an increased risk for a&nbsp;certain type of stroke known as a <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000726.htm\" target=\"_blank\">hemorrhagic stroke</a>.&nbsp;First-line therapy&nbsp;consists of a steroid such as <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682792.html\" target=\"_blank\">dexamethasone</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682206.html\" target=\"_blank\">hydrocortisone</a>. This will often correct the overproduction of aldosterone, lower the blood pressure, and correct the potassium levels.[9061]","dateModified":"2015-06-12T17:04:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":7456,"relatedDiseaseName":"Primary hyperaldosteronism","relation":"Parent","isRare":false,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15498,"phenoTypeName":"Dexamethasone-suppressible primary hyperaldosteronism","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":384,"phenoTypeName":"Abnormal circulating renin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1388,"phenoTypeName":"Adrenal hyperplasia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4251,"phenoTypeName":"Caesarian section","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5714,"phenoTypeName":"Epistaxis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4308,"phenoTypeName":"Hypokalemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13845,"phenoTypeName":"Intracranial hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13061,"phenoTypeName":"Polydipsia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6947,"phenoTypeName":"Preeclampsia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15505,"phenoTypeName":"Secretory adrenocortical adenoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10434,"phenoTypeName":"Tinnitus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10013,"phenoTypeName":"Abnormality of the urinary system","percentRanges":"-"},{"phenoTypeId":6042,"phenoTypeName":"Adrenogenital syndrome","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":3996,"phenoTypeName":"Decreased circulating renin level","percentRanges":"-"},{"phenoTypeId":6053,"phenoTypeName":"Hyperaldosteronism","percentRanges":"-"},{"phenoTypeId":5250,"phenoTypeName":"Onset","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Glucocorticoid-remediable_aldosteronism"}